Cyclodextrin-PEI-Tat Polymer As a Vector for Plasmid DNA Delivery to Placenta Mesenchymal Stem Cells

Wing-Fu Lai,Gu-Ping Tang,Xin Wang,Guo Li,Hong Yao,Zan Shen,Gang Lu,Wai Sang Poon,Hsiang-Fu Kung,Marie C. M. Lin

DOI: https://doi.org/10.1007/s12668-011-0010-9

2011-01-01

BioNanoScience

Abstract:This study aims to modify a cyclodextrin-PEI-based polymer, PEI-β-CyD, with the TAT peptide for plasmid DNA delivery to placenta mesenchymal stem cells (PMSCs). By using the disulfide exchange between the SPDP-activated PEI-β-CyD and TAT peptide, the TAT-PEI-β-CyD polymer was fabricated and the success of this was confirmed by the presence of characteristic peaks for PEI (at δ 2.8–3.2 ppm), CyD (at δ 5.2, 3.8–4.0 and 3.4–3.6 ppm) and TAT (at δ 1.6–1.9 and 6.8–7.2 ppm) in the 1 H NMR spectrum of TAT-PEI-β-CyD. The polymer–plasmid–DNA polyplex could condense DNA at an N/P ratio of 7.0–8.0, and form nanoparticles with the size of 150.6±5.6 nm at its optimal N/P ratio (20/1). By examining the transfection efficiency and cytotoxicity of TAT-PEI-β-CyD, conjugation of the TAT peptide onto PEI-β-CyD was demonstrated to improve the transfection efficiency of PEI-β-CyD in PMSCs after 48 and 96 hours of post-transfection incubation. The viability of PEI-β-CyD-treated PMSCs was shown to be over 80% after 5 h of treatment and 24 h of post-treatment incubation. In summary, this study showed that the TAT-PEI-β-CyD polymer as a vector for plasmid DNA delivery to PMSCs and other cells warrants further investigations.